FOR AN EPISODE OF CUTANEOUS ERYTHEMA NODOSUM LEPROSUM, THALODA ® (THALIDOMIDE) DOSING SHOULD BE INITIATED AT 100 TO 300 MG/DAY, ADMINISTERED ONCE DAILY WITH WATER, PREFERABLY AT BEDTIME AND AT LEAST 1 HOUR AFTER THE EVENING MEAL. IN PATIENTS WITH A SEVERE CUTANEOUS ENL REACTION, OR IN THOSE WHO HAVE PREVIOUSLY REQUIRED HIGHER DOSES TO CONTROL THE REACTION, THALODA ® (THALIDOMIDE) DOSING MAY BE INITIATED AT HIGHER DOSES UP TO 400 MG/DAY ONCE DAILY AT BEDTIME OR IN DIVIDED DOSES WITH WATER, AT LEAST 1 HOUR AFTER MEALS.
IN PATIENTS WITH MODERATE TO SEVERE NEURITIS ASSOCIATED WITH A SEVERE ENL REACTION, CORTICOSTEROIDS MAY BE STARTED CONCOMITANTLY WITH THALODA ® (THALIDOMIDE). STEROID USAGE CAN BE TAPERED AND DISCONTINUED WHEN THE NEURITIS HAS AMELIORATED.